JBPOS0101

· Bio-Pharm Solutions Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JBPOS0101, covering 2023-02-16 to 2023-02-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients [Phase 2]